SEC Form 4 · accession 0001209191-17-004636
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Stack
Officer — CEO and Chairman · Director
Period of report
Jan 17, 2017
Accepted (ET)
Jan 19, 2017 · 6:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 17, 2017 | M | 15,000 | $5.49 | A | 78,870 | D | |
| Common StockF3 | Jan 17, 2017 | S | 13,700 | $38.37 | D | 65,170 | D | |
| Common StockF4 | Jan 17, 2017 | S | 1,300 | $38.81 | D | 63,870 | D | |
| Common StockF5 | holding | — | — | — | 18,596 | I | By Stack Schroon Mohawk FLP | |
| Common StockF5 | holding | — | — | — | 1,208 | I | By LCK Investment LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F6 | $5.49 | Jan 17, 2017 | M | 15,000 | D | — | Dec 29, 2020 | Common Stock | 15,000 | 15,610 | D |
Explanation of responses
- F1The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- F2Includes 233 shares of common stock acquired under the issuer's employee stock purchase plan in December 2016.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.75 to $38.70, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 and 4.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.75 to $38.90, inclusive.
- F5Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC.
- F6The stock option vested as to 25% of the option shares on December 29, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.